Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion.
Aged
Aged, 80 and over
Ataxia
/ complications
Cerebellar Ataxia
/ physiopathology
Cerebellum
/ physiopathology
Female
Humans
Male
Middle Aged
Neurologic Examination
/ adverse effects
Peripheral Nervous System Diseases
/ complications
Reflex, Abnormal
/ physiology
Sensation Disorders
/ etiology
Syndrome
Vestibular Neuronitis
/ complications
RFC1
cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS)
chronic cough
repeat expansion
sensory neuropathy
Journal
Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537
Informations de publication
Date de publication:
01 02 2020
01 02 2020
Historique:
received:
05
08
2019
revised:
21
11
2019
accepted:
27
11
2019
entrez:
11
2
2020
pubmed:
11
2
2020
medline:
7
7
2020
Statut:
ppublish
Résumé
Ataxia, causing imbalance, dizziness and falls, is a leading cause of neurological disability. We have recently identified a biallelic intronic AAGGG repeat expansion in replication factor complex subunit 1 (RFC1) as the cause of cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) and a major cause of late onset ataxia. Here we describe the full spectrum of the disease phenotype in our first 100 genetically confirmed carriers of biallelic repeat expansions in RFC1 and identify the sensory neuropathy as a common feature in all cases to date. All patients were Caucasian and half were sporadic. Patients typically reported progressive unsteadiness starting in the sixth decade. A dry spasmodic cough was also frequently associated and often preceded by decades the onset of walking difficulty. Sensory symptoms, oscillopsia, dysautonomia and dysarthria were also variably associated. The disease seems to follow a pattern of spatial progression from the early involvement of sensory neurons, to the later appearance of vestibular and cerebellar dysfunction. Half of the patients needed walking aids after 10 years of disease duration and a quarter were wheelchair dependent after 15 years. Overall, two-thirds of cases had full CANVAS. Sensory neuropathy was the only manifestation in 15 patients. Sixteen patients additionally showed cerebellar involvement, and six showed vestibular involvement. The disease is very likely to be underdiagnosed. Repeat expansion in RFC1 should be considered in all cases of sensory ataxic neuropathy, particularly, but not only, if cerebellar dysfunction, vestibular involvement and cough coexist.
Identifiants
pubmed: 32040566
pii: 5733001
doi: 10.1093/brain/awz418
pmc: PMC7009469
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
480-490Subventions
Organisme : Wellcome Trust
ID : 206675/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025431/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N010035/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000848
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025431/2
Pays : United Kingdom
Organisme : European Research Council
ID : 309548
Pays : International
Organisme : Medical Research Council
ID : MR/S01165X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T001712/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203148/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 212219/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601943
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
Références
J Neurol. 2018 Jun;265(6):1454-1462
pubmed: 29696497
Am J Hum Genet. 2019 Jul 3;105(1):151-165
pubmed: 31230722
Laryngoscope. 2012 Aug;122(8):1858-61
pubmed: 22645067
Brain. 2004 Feb;127(Pt 2):280-93
pubmed: 14607788
Eye (Lond). 2015 Feb;29(2):163-70
pubmed: 25412719
Auris Nasus Larynx. 2018 Aug;45(4):866-870
pubmed: 29089158
J Neurol Sci. 2018 Apr 15;387:75-79
pubmed: 29571876
Neurology. 2014 Apr 22;82(16):1410-5
pubmed: 24682971
Brain. 1991 Feb;114 ( Pt 1A):1-11
pubmed: 1998877
Acta Neuropathol. 1969;13(3):197-216
pubmed: 5805973
JAMA. 2019 Jun 4;321(21):2131-2133
pubmed: 31162561
Semin Neurol. 1987 Mar;7(1):58-66
pubmed: 3332448
Neurol Clin Pract. 2016 Feb;6(1):61-68
pubmed: 26918204
J Neurol. 2016 Feb;263(2):245-249
pubmed: 26566912
Brain. 2014 Oct;137(Pt 10):2649-56
pubmed: 25070514
Diabetes Care. 1985 Sep-Oct;8(5):491-8
pubmed: 4053936
J Vestib Res. 2017;27(4):177-189
pubmed: 29081426
Ann N Y Acad Sci. 2011 Sep;1233:139-47
pubmed: 21950986
Nat Genet. 2019 Apr;51(4):649-658
pubmed: 30926972
Brain. 2009 Jul;132(Pt 7):1723-33
pubmed: 19506068
Eur J Neurol. 2018 Apr;25(4):659-665
pubmed: 29316033
PLoS One. 2013 May 09;8(5):e61862
pubmed: 23671577
Ann Neurol. 2000 Jan;47(1):104-9
pubmed: 10632108
Brain. 1999 Jul;122 ( Pt 7):1293-303
pubmed: 10388795
Brain. 1985 Dec;108 ( Pt 4):897-924
pubmed: 4075078